Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to comments from some lawmakers suggesting a repeal of drug pricing solutions passed as part of the Inflation Reduction Act of 2022. “Washington finally […]
Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with $1.3 Billion Investment from American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday reacting to reports that brand name drug company Moderna is considering hiking the price of the company’s COVID-19 vaccine as […]
Biden Administration and Congress Deliver Positive Progress on Longstanding Commitments to Lower Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden signing H.R. 5376, the Inflation Reduction Act of 2022, into law. “CSRxP applauds President Biden […]
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Hundreds of Millions of Dollars on False and Hyperbolic Claims For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on the U.S. House of Representatives’ passage of the Inflation Reduction Act […]
Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down on the Pharmaceutical Industry’s Egregious Practices, Deliver Relief for American Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Sunday on the U.S. Senate passage of the Inflation Reduction Act […]
Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will Help Hold Brand Name Drug Companies Accountable, Support Pharmaceutical Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday following the passage of the Interagency Patent Coordination and Improvement Act of 2022 in […]
Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable for Egregious Anti-Competitive and Pricing Practices to Lower Rx Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. […]
Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Pointing Fingers at Others to Evade Accountability For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a first batch of price increases on brand name drugs from manufacturers as […]
Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Americans Hurt By Brand Name Drug Companies’ Egregious Practices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to reports Congressional leaders will introduce a revised reconciliation package with a significant […]
Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game and Deliver on Repeated Promises to Lower Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced the start of a five-month, seven-figure advertising campaign Thursday in Washington, D.C. and target states […]